Neurocrine Biosciences Inc. has announced that Sanjay Keswani, M.D. will take over as Chief Medical Officer effective June 2, 2025, succeeding Eiry W. Roberts, M.D., who has held the position for the past seven years. Dr. Roberts will transition to a strategic advisory role, continuing her association with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000914475-25-000139), on May 30, 2025, and is solely responsible for the information contained therein.